Lyell Immunopharma, Inc. (LYEL) NASDAQ
19.24
-0.01(-0.05%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
19.24
-0.01(-0.05%)
Currency In USD
| Market Cap | 526.12M |
| Enterprise Value | 507.86M |
| P/E Ratio | -1.71 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 14,482.19 |
| Price/Book Ratio | 1.54 |
| Enterprise/Revenue | 12,827.9 |
| Enterprise/EBITDA | -2.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -7,948.58 |
| Operating Margin | -6,189.1 |
| Return On Assets | -0.7 |
| Return On Equity | -0.86 |
| Revenue | 36,000 |
| Revenue/Share | 0 |
| Gross Profit | -11.5M |
| EBITDA | -192.24M |
| Net Income | -274.45M |
| Diluted EPS | -16.06 |
| Total Cash | 254.02M |
| Total Cash/Share | 11.61 |
| Total Debt | 39.49M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 7.23 |
| Book Value Per Share | 12.51 |
| 52-Week Change | 137.82 |
| 52-Week High | 45 |
| 52-Week Low | 7.65 |
| Moving Average 50 Days | 21.86 |
| Moving Average 200 Days | 20.26 |
| Average Volume | 95,136 |
| Shares Outstanding | 23.33M |
| % Held by Institutions | 62.43 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | June 02, 2025 |